Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.
Read more https://www.sciencedaily.com/releases/2023/09/230906171827.htm